29-Jul-2021 | Facts and Factors
Findings from Facts & Factors report “Adult and Pediatric Hemoconcentrators Market By Product Type (Pediatric Hemoconcentrators and Adult Hemoconcentrators) and End-Use (Hospitals, Ambulatory Surgical Centre, and Others): Global & Regional Industry Perspective, Comprehensive Analysis, and Forecasts, 2021 – 2026” states that the global adult and pediatric hemoconcentrators market in 2020 was approximately USD 12 Million. The market is anticipated to grow at a CAGR of 4% and is anticipated to reach around USD 16 Million by 2026.
Hemoconcentrator is used to extract excess fluid from a patient's vascular system. Hemoconcentrators are used to monitor hemodilution and hematocrit during extracorporeal bypass surgery. Hemoconcentrators are semipermeable membranes that allow water and electrolytes to move out of the blood. They are also known as hemofilter or ultrafiltration devices. They are used instead of diuretics to remove excess fluid and electrolytes from the perfusate and to increase the hematocrit. Hemoconcentrators are used in the extracorporeal circuit to monitor hemodilution, keep hematocrit levels stable, and reduce the need for additional blood products during and after surgery. The hemoconcentration comes in a variety of sizes and glycerine-free polysulfone membranes for excellent biocompatibility. It also facilitates insertion and aids in maintaining a higher hematocrit and fluid level. By reducing the risk of post-operative bleeding, hemoconcentration reduces the need for homologous blood and blood supplies.
Browse the full report “Adult and Pediatric Hemoconcentrators Market By Product Type (Pediatric Hemoconcentrators and Adult Hemoconcentrators) and End-Use (Hospitals, Ambulatory Surgical Centre, and Others): Global & Regional Industry Perspective, Comprehensive Analysis, and Forecasts, 2021 – 2026” at https://www.fnfresearch.com/adult-and-pediatric-hemoconcentrators-market
Cardiac bypass surgery is the most common form of heart surgery used to treat patients with serious heart disease. Hemoconcentrators are increasingly being used during cardiac bypass surgery. Surgical specialists are favored. Controlling hemodilution during cardiopulmonary surgery using hemoconcentration. After CPB, hemoconcentrators may be used to concentrate the pumped blood until it is returned to the patient through a bag or directly via the patient's venous line. Hemoconcentrators, unlike cell savers, save platelets, albumin, and coagulation factors. Customized hemoconcentrators for children and adults are readily available, allowing for better healthcare options. As a result, a trustworthy health analysis is generated, encouraging market growth. The advantages of hemoconcentrators, which enable direct access to the extracorporeal circuit during surgery, are expected to drive market demand. However, the shortage of hemoconcentrator replacements, as well as the various problems associated with hemoconcentrators and a lack of expertise, may all delay the global market's development. Nonetheless, a favorable regulatory climate for medical devices is essential to strengthen current healthcare infrastructure and enable industry leaders to introduce new innovations. Medivators, a large multinational corporation that sells a range of pediatric hemoconcentrators including the HPH Mini and Hemocor HPH Junior, for example, may see a boost in market share.
On the basis of product form and end-use, the adult and pediatric hemoconcentrators markets are divided. The market is segmented into pediatric hemoconcentrators and adult hemoconcentrators based on the product form. Adult hemoconcentrators accounted for the largest market share due to the growing prevalence of cardiovascular disease among the elderly adult population. The market is divided into three categories based on end-use: ambulatory surgical centers, hospitals, and others. The hospital segment is expected to grow significantly over the study period, owing to changing dietary habits and an aging patient base susceptible to a variety of diseases due to a weakened immune system. In addition, developments in glycerine-free polysulfone membrane hemoconcentrators with exclusive biocompatibility for a broad range of medical device applications have boosted overall segmental growth.
Adult and pediatric hemoconcentrators will have a significant sales share in North America by 2026. An increasing number of R&D activities in North America will drive regional growth, thanks to technological advancements. Furthermore, since heart failure is the leading cause of death in the United States, hemoconcentrators come in a variety of sizes to make cardiac bypass surgery easier, allowing for business growth. Asia Pacific is expected to expand at a high CAGR during the forecast period, owing to an increase in the prevalence of cardiovascular diseases in the area. Despite being preventable, cardiovascular diseases are the leading cause of death in the Asia Pacific, according to the Organisation for Economic Co-operation and Development (OECD). Cardiovascular diseases killed an estimated 9.3 million people in the United States in 2012, accounting for about one-third of all deaths.
Top Market Players
Some of the key players in the adult and pediatric hemoconcentrators market are Andocor, LivaNova Plc, Maquet, Medica S.p.A, Terumo Corporation, Medivators, Nipro, Medtronic, Sorin, Isla Lab, Getinge, Palex Medical, Spictra, and AMS. To gain a credible foothold in the global economy, these multinational corporations have used a range of strategies, including purchasing alliances, shares, contracts, collaborations, joint ventures, new product launches, transactions, and mergers and acquisitions. Medivators, for example, announced in 2017 that its direct distribution activities in Australia will be expanded. The firm's commercial platform was strengthened as a result of this strategy, which had a positive impact on industry growth. Furthermore, in order to boost their corporate presence and market share, leading corporations often participate in dynamic merger and acquisition operations. For example, LivaNova, Plc was formed when Sorin S.p.A, an Italian hemoconcentrator manufacturer, merged with Cyberonics, Inc., a US-based company. As a result of the merger, the combined company is expected to grow and expand its global scope.
This report segments the adult and pediatric hemoconcentrators market as follows:
Global Adult and Pediatric Hemoconcentrators Market: By Product Type Segmentation Analysis:
- Pediatric Hemoconcentrators
- Adult Hemoconcentrators
Global Adult and Pediatric Hemoconcentrators Market: By End-Use Segmentation Analysis
- Ambulatory Surgical Centre
Global Adult and Pediatric Hemoconcentrators Market: Regional Segmentation Analysis
- North America
- The UK
- Rest of Europe
- Asia Pacific
- South Korea
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Facts & Factors
A 2108, Sargam,
Pune 411041, India